IQV · Iqvia Holdings Inc.
$236.66
-4.86 (-2.01%)
At close · Aug 14
Market Cap
$40.31B
Shares
166.90M
Iqvia Holdings Inc. Earnings Call Transcripts
Every quarterly earnings call for Iqvia Holdings Inc. (IQV) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲5%
$3.56B
$283.00M
'22 Q3
22-10-26
▲2.8%
$3.74B
$227.00M
'22 Q4
23-02-10
▲2.4%
$3.65B
$289.00M
'23 Q1
23-04-27
▲5.3%
$3.73B
$297.00M
'23 Q2
23-08-01
▲4.9%
$3.74B
$303.00M
'23 Q3
23-11-01
▲3.5%
$3.87B
$469.00M
'23 Q4
24-02-14
▲2.3%
$3.74B
$288.00M
'24 Q1
24-05-02
▲2.3%
$3.81B
$363.00M
'24 Q2
24-07-22
▲4.3%
$3.90B
$285.00M
'24 Q3
24-10-31
▲2.3%
$3.96B
$437.00M
'24 Q4
25-02-06
▲2.5%
$3.83B
$249.00M
'25 Q1
25-05-06
▲5.3%
$4.02B
$266.00M
'25 Q2
25-07-22
▲5.2%
$4.10B
$331.00M
'25 Q3
25-10-28
▲10.3%
$4.36B
$514.00M
'25 Q4
26-02-05
LATEST
▲8.4%
$4.15B
$274.00M
'26 Q1
26-05-05
Earnings call
FY26 · Q2
2026-07-28
Q2 2026 IQVIA Earnings Conference Call
Confident tone
Raised full-year guidance
Q2 financial beat vs guidance
Commercial solutions growth acceleration
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Iqvia Holdings Inc. Q1 FY2026 Earnings Call
Confident tone
R&D Solutions / Clinical bookings and backlog
Financial results and guidance
Segment reporting restructuring
Revenue
$4.15B
▲ 8.4% YoY Diluted EPS
$1.61
▲ 15% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-12
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-09
Leerink Partners 2026 Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-05
Iqvia Holdings Inc. Q4 FY2025 Earnings Call
Confident tone
Commercial performance
Organizational simplification in 2026
Margin and pass-throughs
Revenue
$4.36B*
▲ 10.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Iqvia Holdings Inc. Q3 FY2025 Earnings Call
Confident tone
R&D Solutions and Phase I expansion
TAS and drug launches
Clinical bookings and backlog
Revenue
$4.10B
▲ 5.2% YoY Diluted EPS
$1.93
▲ 24.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-22
Iqvia Holdings Inc. Q2 FY2025 Earnings Call
Positive tone
Quarterly financial results
TAS / commercial business
Market environment and policy uncertainty
Revenue
$4.02B
▲ 5.3% YoY Diluted EPS
$1.54
▼ 21.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Iqvia Holdings Inc. Q1 FY2025 Earnings Call
Positive tone
R&DS clinical environment
Backlog and demand metrics
FSP vs full service mix
Revenue
$3.83B
▲ 2.5% YoY Diluted EPS
$1.40
▼ 10.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-06
Iqvia Holdings Inc. Q4 FY2024 Earnings Call
Positive tone
R&DS Demand and Cancellations
TAS Segment Recovery
Guidance and 2025 Outlook
Revenue
$3.96B*
▲ 2.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Iqvia Holdings Inc. Q3 FY2024 Earnings Call
Positive tone
Mega-trial delays and cancellations
TAS (short-cycle) recovery
Backlog and book-to-bill
Revenue
$3.90B
▲ 4.3% YoY Diluted EPS
$1.55
▼ 4.9% YoY Gross margin
23.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-22
Iqvia Holdings Inc. Q2 FY2024 Earnings Call
Positive tone
TAS / Technology & Analytics
R&DS / Clinical Bookings and Backlog
Capital Allocation and M&A Pipeline
Revenue
$3.81B
▲ 2.3% YoY Diluted EPS
$1.97
▲ 23.9% YoY Gross margin
22.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Iqvia Holdings Inc. Q1 FY2024 Earnings Call
Positive tone
CNS cancellation and revenue impact
Strategic partnerships and technology wins
R&D clinical demand and backlog
Revenue
$3.74B
▲ 2.3% YoY Diluted EPS
$1.56
▲ 2% YoY Gross margin
22.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-14
Iqvia Holdings Inc. Q4 FY2023 Earnings Call
Positive tone
2024 financial guidance and headwinds
R&D Solutions bookings and backlog
Pricing pressure and negotiation dynamics
Revenue
$3.87B*
▲ 3.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Iqvia Holdings Inc. Q3 FY2023 Earnings Call
Revenue
$3.74B
▲ 4.9% YoY Diluted EPS
$1.63
▲ 9.4% YoY Gross margin
23.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Iqvia Holdings Inc. Q2 FY2023 Earnings Call
Revenue
$3.73B
▲ 5.3% YoY Diluted EPS
$1.59
▲ 18.7% YoY Gross margin
22.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
Iqvia Holdings Inc. Q1 FY2023 Earnings Call
Revenue
$3.65B
▲ 2.4% YoY Diluted EPS
$1.53
▼ 8.9% YoY Gross margin
22.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-10
Iqvia Holdings Inc. Q4 FY2022 Earnings Call
Revenue
$3.74B*
▲ 2.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-26
Iqvia Holdings Inc. Q3 FY2022 Earnings Call
Revenue
$3.56B
▲ 5% YoY Diluted EPS
$1.49
▲ 11.2% YoY Gross margin
22.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Iqvia Holdings Inc. Q2 FY2022 Earnings Call
Revenue
$3.54B
▲ 3% YoY Diluted EPS
$1.34
▲ 48.9% YoY Gross margin
22.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Iqvia Holdings Inc. Q1 FY2022 Earnings Call
Revenue
$3.57B
▲ 4.7% YoY Diluted EPS
$1.68
▲ 54.1% YoY Gross margin
22.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
Iqvia Holdings Inc. Q4 FY2021 Earnings Call
Revenue
$3.64B*
▲ 10.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-21
Iqvia Holdings Inc. Q3 FY2021 Earnings Call
Revenue
$3.39B
▲ 21.7% YoY Diluted EPS
$1.34
▲ 157.7% YoY Gross margin
21.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Iqvia Holdings Inc. Q2 FY2021 Earnings Call
Revenue
$3.44B
▲ 36.4% YoY Diluted EPS
$0.90
Gross margin
20.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-22
Iqvia Holdings Inc. Q1 FY2021 Earnings Call
Revenue
$3.41B
▲ 23.8% YoY Diluted EPS
$1.09
▲ 159.5% YoY Gross margin
21.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-10
Iqvia Holdings Inc. Q4 FY2020 Earnings Call
Revenue
$3.30B
▲ 13.9% YoY Diluted EPS
$0.61
▲ 577.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-20
Iqvia Holdings Inc. Q3 FY2020 Earnings Call
Revenue
$2.79B
▲ 0.6% YoY Diluted EPS
$0.52
▲ 79.3% YoY Gross margin
21.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-22
Iqvia Holdings Inc. Q2 FY2020 Earnings Call
Revenue
$2.52B
▼ 8% YoY Diluted EPS
$-0.12
▼ 140% YoY Gross margin
17.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Iqvia Holdings Inc. Q1 FY2020 Earnings Call
Revenue
$2.75B
▲ 2.6% YoY Diluted EPS
$0.42
▲ 44.8% YoY Gross margin
19.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-12
Iqvia Holdings Inc. Q4 FY2019 Earnings Call
Revenue
$2.90B
▲ 7.7% YoY Diluted EPS
$0.09
▼ 73.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 earnings calls
Key facts
CIK
1478242
CUSIP
46266C105
13F (30d)
1009 filings
977 filers
Visit website
Investor relations